Difference between revisions of "Minutes - Referral WG 2023-03-10"
From Health Level 7 Belgium Wiki
KarlienErauw (talk | contribs) |
KarlienErauw (talk | contribs) |
||
Line 3: | Line 3: | ||
* Bart Decuypere | * Bart Decuypere | ||
* Bart Reekmans | * Bart Reekmans | ||
+ | * Ben Goosse | ||
* Emily Sevrin | * Emily Sevrin | ||
* Geert Vandenhole | * Geert Vandenhole | ||
Line 17: | Line 18: | ||
=== Excused === | === Excused === | ||
* Anthony Maton | * Anthony Maton | ||
− | |||
* Benjamien Schmitt | * Benjamien Schmitt | ||
* Christophe Behaegel | * Christophe Behaegel | ||
Line 38: | Line 38: | ||
=== Meeting Minutes === | === Meeting Minutes === | ||
* Feedback from Steering Committee on 7 March: | * Feedback from Steering Committee on 7 March: | ||
− | ::* | + | ::* [https://github.com/hl7-be/referral/issues/187 Medication issue] ask the prescriber softs that when they copy the medication (dose/posology, administration) info in the digital nursing referral prescription |
− | ::::* but what when the posology changes ? | + | ::::* but what when the posology changes ? softs are not in favour of this solution (updating - duplicating referrals) |
+ | ::::* we need to list the use cases, Anne will provide this for review by this WG | ||
+ | ::::* issue is being updated | ||
+ | |||
Revision as of 08:21, 10 March 2023
Attendees
- Anne Nerenhausen
- Bart Decuypere
- Bart Reekmans
- Ben Goosse
- Emily Sevrin
- Geert Vandenhole
- Hans De Keersmaecker
- Jean-Michel Polfliet
- Julien Beard
- Karlien Erauw
- Lionel Cremer
- Maarten Cobbaert
- Maxime Daive
- Philippe Baise
- Robin Merckx
Excused
- Anthony Maton
- Benjamien Schmitt
- Christophe Behaegel
- Cyprien Janssens
- Dorsan de Fabricheckers
- Jacques Yakoub
- Jean-Francois Coquelet
- José Costa Teixeira
- Katleen Smedts
- Katrien Dickx
- Laurent Lamouline
- Marleen Van Eygen
- Pablo Christiaens
- Pieter Devolder
- Richard Francken
Agenda
- Resolution of issues
Meeting Minutes
- Feedback from Steering Committee on 7 March:
- Medication issue ask the prescriber softs that when they copy the medication (dose/posology, administration) info in the digital nursing referral prescription
- but what when the posology changes ? softs are not in favour of this solution (updating - duplicating referrals)
- we need to list the use cases, Anne will provide this for review by this WG
- issue is being updated
- Valuesets: first version was presented 2 week ago - no update
- the discipline is a transversal valuesets and is being looked into by some hospitals, valueset comes from Cobhra so no need to review
- the first version is final and there will be no changes for the first release
- BodySite is transversal and lead by Anne
- Annex 81 use case : work awaits steerco decision
- Issue 5: mapping needs to be done, by Bart
- Issue 10: remains open, awaiting info from José
- Issue 47: how to handle duplicates of a service request, is resolved & closed
- we don't need a link with the original service request for a duplicate so we can drop the third option and close the issue
- Issue 54: description of custom operations, these will be part of the IG
- Issue 53: linked to issue 54
- Issue 52: linked to issue 54
- no definite list of custom operations available yet - input needed from Anthony, work
- the idea is to have as few operations as possible
- Issue 77: linked to bodyparts - needs to be checked by RIZIV/Maarten
- Issue 126: needs to be checked by RIZIV, linked to use case multiple prescribers
- Issue 168: is ongoing, will only be closed once all use cases are tackled
- Issue 187: will remain open, linked to SteerCo committee/RIZIV & afterwards needing info from WG Medication
- Issue 191: both structure and businessrules can change due to evolutions in the legislation, awaiting a proposal from Anthony in the spirit of looking at HL7 int'l - to decide in WG FHIR infra & scty
- Issue 205: valueset v1/phase 1 is final so apart from BodySite (transversal) all is resolved
- where will we put the valueset of Route ? needs to be discussed, linked to feedback from SteerCo
- Issue 197: valueset v1/phase 1 is final so issue can be closed - please note that there will be updates on the valuesets from time to time though
- Issue 195: valueset v1/phase 1 is final so issue can be closed - please note that there will be updates on the valuesets from time to time though
- Issue 194: duplicate to issue 168, so issue can be closed
- Issue 169: meetings will happen with NIC/CIN led by Maarten, normally there will be an update by next week
- Issue 167: if value sets are final, this can be closed
- Progress on use cases :
- use cases are ready on medication administration and blood sample : included in IG
- on annex 81 awaiting info
- multiple prescribers : no progress has been made
- By next week there will be feedback from the Steering committee
Agenda next meeting
- feedback on use cases
- input on issues to continue resolution of issues : we will have to assess upfront if we have sufficient additional input by next Friday to be able to have an efficient meeting or not
Next meeting: next week Friday 17 March at 9AM